DR. PHILLIP S PANG, MD, PHD
Osteopathic Medicine at Pasteur Dr, Palo Alto, CA
License number
California A92175
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 723-6661
(650) 208-6232
(650) 208-6232
Professional information
Dr. Phillip S Pang, Stanford CA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
300 Pasteur Dr STE S101, Stanford 94305
(650) 723-6661 (Phone)
(650) 723-6661 (Phone)
Certifications:
Infectious Disease, 2009, Internal Medicine, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
300 Pasteur Dr STE S101, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 2001
Columbia University / College of Physicians And Surgeons
Graduated: 2001
Phillip S Pang, Stanford CA
Specialties:
Infectious Disease Specialist
Address:
300 Pasteur Dr, Stanford, CA 94305
Phillip Soon-Ho Pang, Stanford CA
Specialties:
Internal Medicine, Infectious Disease
Work:
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Education:
Columbia University (2004)
Rapid High Resolution, High Throughput Rna Structure, Rna-Macromolecular Interaction, And Rna-Small Molecule Interaction Mapping
US Patent:
2013028, Oct 31, 2013
Filed:
Oct 21, 2011
Appl. No.:
13/880314
Inventors:
Jeffrey S. Glenn - Palo Alto CA, US
Phillip S. Pang - Palo Alto CA, US
Shripa Patel - Stanford CA, US
Phillip S. Pang - Palo Alto CA, US
Shripa Patel - Stanford CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12Q 1/70
US Classification:
506 9, 435 612, 435 5, 435 611, 702 20
Abstract:
Compositions and methods are provided for a rapid, high-resolution, high-throughput method for determining the intramolecular interactions between the nucleotides present in an polynucleotide, such that single-stranded nucleotides, and nucleotides in a double-stranded configuration are distinguished and identified. Tertiary contacts and solvent accessible regions may also be determined, where such contacts and regions may result from a single stranded configuration, intermolecular interactions with other macromolecules including, without limitation, DNA, protein, RNA, etc.; intermolecular interactions with small molecules which may include drug candidates; or a combination of macromolecules and small molecules.
Pip-2 Inhibition-Based Antiviral And Anti-Hyperlipidemic Therapies
US Patent:
2011026, Oct 27, 2011
Filed:
May 29, 2009
Appl. No.:
12/994414
Inventors:
Jeffrey S. Glenn - Palo Alto CA, US
Phillip S. Pang - Palo Alto CA, US
Nam-Joon Cho - Stanford CA, US
Choongho Lee - Palo Alto CA, US
Phillip S. Pang - Palo Alto CA, US
Nam-Joon Cho - Stanford CA, US
Choongho Lee - Palo Alto CA, US
International Classification:
A61K 33/00, A61K 31/7036, A61P 31/12, G01N 33/53
US Classification:
424722, 436501, 514 39
Abstract:
Interaction of a specific viral domain with phosphatidylinositol 4,5-bisphosphate (PIP 2) is shown to mediate viral replication. Basic Amino Acid PIP-2 Pincer (BAAPP) domains are described herein, including, without limitation, NS5A protein of HCV, NS4B protein of HCV, poliovirus, and rhinovirus.